688526 科前生物
按盤價 
19.330 +1.230 (+6.796%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.501 | 9.833 | 10.799 | 12.316 | 19.473 |
| 總資產報酬率 ROA (%) | 4.848 | 8.342 | 8.738 | 10.092 | 16.698 |
| 投入資產回報率 ROIC (%) | 5.215 | 9.019 | 9.521 | 11.172 | 18.440 | 邊際利潤分析 |
| 銷售毛利率 (%) | 67.283 | 63.756 | 72.093 | 73.611 | 79.805 |
| 營業利潤率 (%) | 52.072 | 46.591 | 43.148 | 46.612 | 59.927 |
| 息稅前利潤/營業總收入 (%) | 45.644 | 39.977 | 36.768 | 40.267 | 53.972 |
| 淨利潤/營業總收入 (%) | 44.999 | 40.501 | 37.176 | 40.863 | 51.734 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 90.604 | 89.957 | 112.821 | 99.502 | 98.501 |
| 價值變動淨收益/利潤總額(%) | 6.641 | 8.582 | 2.041 | 1.735 | 0.777 |
| 營業外收支淨額/利潤總額(%) | -0.066 | -0.163 | -0.339 | -0.023 | -0.144 | 償債能力分析 |
| 流動比率 (X) | 5.716 | 5.336 | 3.384 | 4.105 | 3.578 |
| 速動比率 (X) | 5.387 | 5.065 | 3.193 | 3.834 | 3.357 |
| 資產負債率 (%) | 11.372 | 12.296 | 17.845 | 20.307 | 15.339 |
| 帶息債務/全部投入資本 (%) | 3.460 | 2.797 | 9.728 | 9.042 | 3.393 |
| 股東權益/帶息債務 (%) | 2,733.146 | 3,398.015 | 910.127 | 970.482 | 2,777.643 |
| 股東權益/負債合計 (%) | 779.068 | 712.912 | 460.132 | 392.198 | 551.875 |
| 利息保障倍數 (X) | -7.139 | -6.115 | -5.897 | -6.356 | -9.197 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 116.072 | 127.304 | 110.821 | 106.339 | 68.653 |
| 存貨周轉天數 (天) | 151.709 | 142.568 | 190.461 | 189.534 | 145.359 |
| 備註： | 即時報價更新時間為 26/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
